Research groups
Colleges
Philip Turner
B.Sc, Ph.D
Manager and Senior Researcher, NIHR HRC in Community Healthcare
Biography
Manager and Senior Researcher, NIHR HRC in Community Healthcare and Infections, Respiratory and Acute Care Research Group. From Jan 2024
Manager and Senior Researcher, NIHR Community Healthcare MIC and Infections and Acute Care Research Group. Jan 2018 - December 2023
Researcher and Industry Liaison, NIHR Diagnostics Evidence Cooperative Oxford. Nov 2014 - Dec 2017
Research Scientist, Department of Physiology, Anatomy and Genetics, University of Oxford. July 2009 - Nov 2014
PhD Cell Physiology, Department of Biology, University of York. Sept 2004 - Sept 2008
BSc (hons) Biological Sciences, School of Biology, University of Newcastle. Sept 1997 - July 2000
Research interests
The National Institute for Health Research (NIHR) HealthTech Research Centre in Community Healthcare (HRC), focuses on the robust in-context evaluation and development of diagnostic devices and in vitro diagnostic tests of relevance to community healthcare. I am a diagnostics researcher and Manager of the HRC in Community Healthcare. My role incorporates responsibility for liaising with members of the in vitro diagnostics industry and facilitating interactions with the HRC research team. My research has focussed on the diagnostic needs of clinicians, barriers to implementation, and the identification of evidence gaps which commonly exist in the evidence base for point-of-care diagnostic tests. I have a personal interest in IVDs which could be deployed in resource-limited settings.
My background is in cell physiology, membrane transport processes and signaling. I have a particular interest in the control of ventilation and in particular how humans respond to changes in the partial pressure of inspired oxygen. I have an associated interest in the physiology and medicine of life in remote regions and at high altitude.
Key publications
-
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)
Journal article
Fanshawe TR. et al, (2024), Clinical Microbiology and Infection, 30, 380 - 386
-
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)
Journal article
Nicholson BD. et al, (2023), PLoS ONE, 18
-
A Diagnostic Accuracy Study to Evaluate Standard Rapid Diagnostic Test (RDT) Alone to Safely Rule Out Imported Malaria in Children Presenting to UK Emergency Departments
Journal article
Bird C. et al, (2023), Journal of the Pediatric Infectious Diseases Society, 12, 290 - 297
-
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
Journal article
Mallett S. et al, (2020), BMC Medicine, 18
-
Impact of point-of-care C reactive protein in ambulatory care: A systematic review and meta-analysis
Journal article
Verbakel JY. et al, (2019), BMJ Open, 9
-
The clinical utility of point-of-care tests for influenza in ambulatory care: A systematic review and meta-analysis
Journal article
Lee JJ. et al, (2019), Clinical Infectious Diseases, 69, 24 - 33
-
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysis
Journal article
Abel L. et al, (2019), International Journal of Technology Assessment in Health Care, 35, 116 - 125
-
Common evidence gaps in point-of-care diagnostic test evaluation: A review of horizon scan reports
Journal article
Verbakel JY. et al, (2017), BMJ Open, 7
-
Frequencies and patterns of laboratory test requests from general practice: A service evaluation to inform point-of-care testing
Journal article
Fanshawe TR. et al, (2018), Journal of Clinical Pathology, 71, 1065 - 1071
Recent publications
-
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy
Journal article
Dorward J. et al, (2024), AIDS, 38, 697 - 702
-
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)
Journal article
Fanshawe TR. et al, (2024), Clinical Microbiology and Infection, 30, 380 - 386
-
Infections diagnosed in children and young people screened for malaria in UK emergency departments: a retrospective multi-centre study
Journal article
Bird C. et al, (2024), Paediatrics and International Child Health
-
What are important areas where better technology would support women's health? Findings from a priority setting partnership.
Journal article
Dixon S. et al, (2023), BMC Womens Health, 23
-
A high-resolution melt curve toolkit to identify lineage-defining SARS-CoV-2 mutations
Journal article
Fraser AJ. et al, (2023), Scientific Reports, 13
-
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
Journal article
Dorward J. et al, (2023), Journal of the International AIDS Society, 26
-
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)
Journal article
Nicholson BD. et al, (2023), PLoS ONE, 18
-
A Diagnostic Accuracy Study to Evaluate Standard Rapid Diagnostic Test (RDT) Alone to Safely Rule Out Imported Malaria in Children Presenting to UK Emergency Departments
Journal article
Bird C. et al, (2023), Journal of the Pediatric Infectious Diseases Society, 12, 290 - 297